Related Experiment Video
Updated: May 24, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Cancer imaging: Gene transcription-based imaging and therapeutic systems
Hyo-eun C Bhang1, Martin G Pomper
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
Abstract:
Molecular-genetic imaging of cancer is in its infancy. Over the past decade gene reporter systems have been optimized in preclinical models and some have found their way into the clinic. The search is on to find the best combination of gene delivery vehicle and reporter imaging system that can be translated safely and quickly. The goal is to have a combination that can detect a wide variety of cancers with high sensitivity and specificity in a way that rivals the current clinical standard, positron emission tomography with [(18)F]fluorodeoxyglucose. To do so will require systemic delivery of reporter genes for the detection of micrometastases, and a nontoxic vector, whether viral or based on nanotechnology, to gain widespread acceptance by the oncology community. Merger of molecular-genetic imaging with gene therapy, a strategy that has been employed in the past, will likely be necessary for such imaging to reach widespread clinical use.
Insights
Molecular-genetic imaging aims to detect diverse cancers with high sensitivity using novel gene reporter systems. Future success relies on safe, systemic delivery vectors and integration with gene therapy for clinical translation.
Area of Science:
- Oncology
- Molecular Imaging
- Gene Therapy
Background:
- Molecular-genetic imaging for cancer detection is an emerging field.
- Gene reporter systems have advanced in preclinical research and early clinical trials.
- Current research focuses on optimizing gene delivery vehicles and reporter systems for clinical translation.
Purpose of the Study:
- To identify optimal gene delivery vehicles and reporter imaging systems for sensitive and specific cancer detection.
- To develop molecular-genetic imaging that rivals the sensitivity and specificity of positron emission tomography with [(18)F]fluorodeoxyglucose.
- To explore strategies for systemic delivery of reporter genes for detecting micrometastases.
Main Methods:
- Optimization of gene reporter systems in preclinical models.
- Evaluation of viral and nanotechnology-based vectors for systemic gene delivery.
- Investigating the merger of molecular-genetic imaging with gene therapy.
Main Results:
- Gene reporter systems show promise but require further optimization for clinical use.
- Systemic delivery and non-toxic vectors are crucial for widespread acceptance in oncology.
- The combination of molecular-genetic imaging with gene therapy is a viable strategy.
Conclusions:
- Molecular-genetic imaging holds significant potential for cancer detection.
- Safe and effective systemic gene delivery is essential for detecting micrometastases.
- Integrating gene therapy with molecular imaging is key to clinical adoption.
More Related Videos
Related Concept Videos
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

